Date Filed | Type | Description |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2023 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 513 options to buy
@ $0 |
|
05/01/2023 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 1,222 shares
@ $0 |
|
04/03/2023 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 477 options to buy
@ $0 |
|
01/03/2023 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 501 options to buy
@ $0 |
|
12/16/2022 |
4
| Carleone Joseph (Director) has filed a Form 4 on Avid Bioservices, Inc.
Txns:
| Exercised 4,632 restricted stock units
@ $0 Granted 9,612 restricted stock units
@ $0 |
|
10/03/2022 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 527 options to buy
@ $0 |
|
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2022 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 379 options to buy
@ $0 |
|
01/03/2022 |
4
| Carleone Joseph (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 365 options to buy
@ $0 |
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on Avid Bioservices, Inc.
Txns:
| Granted 10,030 options to buy
@ $10.72, valued at
$107.5k
Granted 2,379 restricted stock units
@ $0 |
|
10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2020 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 2,041 shares
@ $0 |
|
04/01/2020 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 759 options to buy
@ $0 |
|
03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2020 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on Avid Bioservices, Inc.
Txns:
| Granted 19,675 options to buy
@ $6.87, valued at
$135.2k
|
|
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2019 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 434 options to buy
@ $0 |
|
09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2019 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 405 options to buy
@ $0 |
|
04/26/2019 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 1,282 shares
@ $0 |
|
04/02/2019 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 439 options to buy
@ $0 |
|
01/02/2019 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Granted 533 options to buy
@ $0 |
|
12/18/2018 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on Avid Bioservices, Inc.
Txns:
| Granted 19,600 options to buy
@ $5.22, valued at
$102.3k
|
|
10/25/2018 |
4
| CARLEONE JOSEPH (Director) has filed a Form 4 on SENSIENT TECHNOLOGIES CORP
Txns:
| Bought 1,000 shares
@ $64.63, valued at
$64.6k
|
|
|